- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Development of the Precision-designed Radiopharmaceuticals Depending on the Targeting Molecules
-
- Fuchigami Takeshi
- Kanazawa University
Bibliographic Information
- Other Title
-
- 疾患や標的分子の特性に応じて精密設計した放射性薬剤の開発
- シッカン ヤ ヒョウテキ ブンシ ノ トクセイ ニ オウジテ セイミツ セッケイ シタ ホウシャセイ ヤクザイ ノ カイハツ
Search this article
Description
<p>Nuclear medicine diagnosis is an in vivo imaging technique that employs radiopharmaceuticals in which diagnostic radionuclides are introduced. This technique facilitates the chronological diagnosis of various diseases and elucidates the pathological mechanisms. Radiopharmaceuticals featuring therapeutic radionuclides are anticipated to surve as a novel cancer therapy due to their potent cytotoxic effects on lesions throughout the body. This review focuses on recent research trends in the development of radiopharmaceuticals for nuclear medicine diagnosis and therapy for cancer and brain diseases, including our studies.</p>
Journal
-
- RADIOISOTOPES
-
RADIOISOTOPES 73 (2), 139-145, 2024-07-15
Japan Radioisotope Association